Novel approach for optimizing the capacity and efficacy of a protamine filter for clinical extracorporeal heparin removal

ASAIO Journal

Volumn 44, Issue 5, 1998, Pages

  Zhang, Yuehua ^a   Singh, Vijendra K ^a   Yang, Victor C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; FILTERS (FOR FLUIDS); PLASTIC FILAMENTS; POLYETHYLENE GLYCOLS;

HEPARIN; PROTAMINE FILTER;

HEMODIALYZERS;

CELLULOSE; HEPARIN; POLYLYSINE; PROTAMINE; PROTAMINE POLY(ETHYLENE GLYCOL); UNCLASSIFIED DRUG;

ARTICLE; BLOOD FILTER; CARDIOPULMONARY BYPASS; DRUG ADSORPTION; EXTRACORPOREAL CIRCULATION; GENE AMPLIFICATION; HEMODIALYSIS; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE;

EID: 0032170881     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199809000-00008     Document Type: Article

References (22)

1. Danishefsky I, Rosenfeld L, Kuhn L, Lahiri B, Whyzmuzis C: Heparin and related polysaccharides, structure and activities. Ann N Y Acad Sci 556: 29-36, 1989.
2. Jaques LB: Heparin: anionic polyelectrolyte drugs. Pharmacol Rev 31: 99-166, 1980.
3. Gavin AG: Complications of heparin therapy. Surg Gynecol Obstet 140: 789-796, 1975.
4. Levine MN, Hirsch J: Hemorrhagic complications of anticoagulant therapy. Semin Thromb Hemostasis 12: 39-57, 1985.
5. Jaques LB: Protamine: antagonist to heparin. Can Med Assoc J 108: 1291-1297, 1973.
6. Ando T, Yamsaki M, Suzuki K: Protamine, in Kleinzeller A (ed), Molecular Biology Biochemistry and Biophysics, New York, Springer-Verlag, 1973, pp. 1-109.
7. Cobb CA III, Fung DL: Shock due to protamine hypersensitivity. Surg Neurol 17: 245-246, 1982.
8. Sharath MD, Metzger WJ, Richerson HB, et al: Protamine induced fatal anaphylaxis. J Thorac Cardiovasc Surg 90: 86-90, 1985.
9. Weiler JM, Gellhaus MA, Carter JG, et al: A prospective study of the risk of an immediate adverse reactions to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol 85: 713-719, 1990.
10. Yang VC: Extracorporeal blood deheparinization system. U.S. patent no. 4,800,016, May 19, 1987.
11. Kim JS, Yang AJ, Yang VC: Protamine immobilization and heparin adsorption on the protamine-bound cellulose fiber membrane. Biotechnol Bioeng 39: 450-456, 1992.
12. Yang VC, Port FK, Kim JS, Teng CL, Till GO, Wakefield TM: The use of immobilization protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 75: 288-297, 1991.
13. Kohn J, Wilchek M: A colorimetric method for monitoring activation of sepharose by cyanogen bromide. Biochem Biophys Res Commun 84: 7-14, 1978.
14. Wang ZJ: Determination of the amino group in chitosan by alkalimetry. Huaxue Shijie 27: 22-23, 1986.
15. Yun JH, Meyerhoff ME, Yang VC: Protamine-sensitive polymer membrane electrode: characterization and bioanalytical applications. Anal Biochem 224: 212-220, 1995.
16. Park KD, Okano T, Nojiri C, Kim SW: Heparin immobilization onto segmented polyurethaneurea surface: effect of hydrophobic spacers. J Biomed Mater Res 22: 977-992, 1988.
17. Ardrade JD: Interfacial phenomena and biomaterials. Med Instrum 7: 110-120, 1976.
18. Mori Y, Nagoaka S: A new antithrombogenic material with long polyethylene oxide chains. Trans Am Soc Artif Intern Organs 28: 459-463, 1982.
19. Nojiri C, Okano T, Jacobs H: Blood compatibility of PEO grafted polyurethane and HEMA/styrene block copolymer surfaces. J Biomed Mater Res 24: 1152-1171, 1990.
20. Kohn J, Wilchek M: A new approach (cyano-transfer) for cyanogen bromide activation of sepharose at neutral pH, which yields activated resins, free of interfering nitrogen derivatives. Biochem Biophys Res Commun 107: 878-884, 1992.
21. Lin SC, Jacobs HA, Kim SW: Heparin immobilization increased through chemical amplification. J Biomed Mater Res 25: 791-795, 1991.
22. Byun Y, Wang T, Kim JS, Yang VC: Optimization and assessment of the in vivo efficacy of a heparin-removing bio-reactor using mathematical modeling. ASAIO J 42: 782-787, 1996.